← Back to Patent Explorer
US3988472A Expired / Lapsed US ⏱️ 0.0 years remaining

Tri-N-propylacetic acid derivatives for therapeutic use

Assignee: Labaz SA
•
Filing: 1975-11-10
•
Granted: 1976-10-26
•
Expires: 1995-11-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Tri-n-propylacetamide and tri-n-propylacetic acid salts are useful in the treatment of pathological variations of mood and as anticonvulsants and tranquillizers.

Inventors

  • 👤 Charles Pigerol
  • 👤 Pierre Luc Eymard

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 09:07
CPC Classifications
C; C07; C07C; C07C255/00; C07C53/00; C07C53/126; C07C53/128

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 34 words
A method of inducing tranquillizing, disinhibiting and antidepressant effects in a subject needing such treatment, said method comprising administering a dosage ranging from 50 to 500 mgs. per day of tri-n-propylacetamide to said subject.
Claim 2
Independent Claim 34 words
A method of inducing tranquillizing, disinhibiting and antidepressant effects in a subject needing such treatment, said method comprising administering a dosage ranging from 50 to 500 mgs. per day of tri-n-propylacetamide to said subject.
Claim 3
Dependent Claim 18 words
The method according to claim 1 wherein the dosage is 100 to 300 mgs. by the oral route.
Claim 4
Dependent Claim 11 words
A method according to claim 1 for the treatment of apragmatism.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-10-26 1980-04-26 1980-10-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-10-26 1984-04-26 1984-10-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-10-26 1988-04-26 1988-10-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag